According to FutureWise analysis the market for CD68 is expected to register a CAGR of 13.10% from 2023-2031.
Cd68 (Cluster of Difference 68) is a protein expressed by monocytes, tissue macrophages, and circulating macrophages. Cancer-associated CD68 is widely used as a diagnostic and prognostic marker. This protein is used to identify neoplasms with macrophage lineages, as well as tumor cells from other lineages. Increasing malignant diseases and research and development are driving the CD68 market. As a histochemical/cytochemical marker of inflammation related to the involvement of monocytes/macrophages, CD68 is routinely used. Cells of macrophage lineage, such as tissue histiocytes, multinucleated giant cells, Kupffer cells, and osteoclasts, were also identified using CD68. In diabetic patients, CD68 plays an important role in diabetes-associated cardiovascular pathology. On the outside of DCs and osteoclasts, CD68 is transiently communicated in the endosomes and lysosomes of macrophages. As a macrophage marker, CD68 has been widely used. A high level of VEGF in serum and stromal cells is associated with thick CD68+ TAMs. It is known that IR reduces the antitumor viability of radiotherapy by regulating VEGF in macrophages.
In addition, CD68 is widely used as an indicator of malignancy. Globally, cancer diseases and diabetes are prevalent and there is an increasing awareness of the need for better health. These factors contribute to the growth of the CD68 market. In spite of this, a reduced overall survival rate in breast cancer is likely to hamper the market's growth. Furthermore, CD68 is expected to create growth opportunities in the market due to research and development. With the development of disease prevention mechanisms and diabetic therapeutic medications, rising awareness about CD68 and a large population are expected to drive market growth. In countries, favorable reimbursement policies and supportive regulatory norms are expected to further drive market growth. A combination of stringent regulations and low per capita income is expected to hamper market growth in fragile economies. Furthermore, higher costs associated with CD68 laboratory research may further hinder market growth.
FutureWise Market Research has instantiated a report that provides an intricate analysis of CD68 Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the CD68 Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.